• Users Online: 60
  • Print this page
  • Email this page
Year : 2021  |  Volume : 15  |  Issue : 1  |  Page : 1-3

NOTTO COVID-19 vaccine guidelines for transplant recipients

1 Department of Nephrology, Institute of Kidney Diseases and Research Center; Dr. H L Trivedi Institute of Transplantation Sciences (IKDRC-ITS), Ahmedabad, Gujarat; Secretary, Indian Society of Organ Transplantation (ISOT), Delhi, India
2 Department of Nephrology, All India Institute of Medical Sciences, Delhi, India
3 Former Professor and Head Nephrology, Banaras Hindu University, Varanasi, Uttar Pradesh; President, Indian Society of Organ Transplantation (ISOT), Delhi, India
4 Department of Transplantation Surgery, Apollo Hospital; Past President, Indian Society of Organ Transplantation (ISOT), Delhi, India
5 Managing Trustee, MOHAN Foundation, Chennai, Tamil Nadu; President-Elect, Indian Society of Organ Transplantation (ISOT), Delhi, India
6 Department of Transplant Surgery, The Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
7 Department of Nephrology, Venkateshwar Hospital, Delhi, India
8 Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
9 Department of Nephrology, Osmania Medical College, Hyderabad, Telangana, India
10 Department of Liver Transplant Surgery, Max Center of Liver and Biliary Sciences at Max Hospital, Saket, Delhi; Past President, Liver Transplant Society of India (LTSI), Kochi, Kerala, India
11 Clinical Professor in Transplantation and Gastrointestinal Surgery, Amrita Institute of Medical Sciences and Research Centre, Kochi, Kerala; President, Department of Cardiovascular Surgery Max Super Specialty Hospital, Saket, New Delhi, India
12 Department of Cardiovascular Surgery Max Super Specialty Hospital, Saket, New Delhi; President, Indian Society for Heart and Lung Transplantation, Delhi, India
13 Director, National Organ and Tissue Transplant Organization, Delhi, India
14 Director General of Health Services, Delhi, India

Correspondence Address:
Dr. Vasanthi Ramesh
Director, National Organ and Tissue Transplant Organization, 4th Floor, National Institute of Pathology, NIOP Building, Safdarjung Hospital Campus, New Delhi - 110 029
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijot.ijot_2_21

Rights and Permissions

In December 2019 Novel corona virus (SARS-CoV-2) infection started in Wuhan and resulted in a pandemic within few weeks' time. Organ transplant recipients being at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection, COVID 19 Vaccine has a significant role in these patients. The vaccine is a safer way to help build protection and would either prevent COVID -19 infection or atleast diminish the severity of the disease. It would also reduce the risk of the continuing transmission and enhance herd immunity. Immuno compromised patients should not receive live vaccines as they can cause vaccine related disease and hence the guidelines suggest that all transplant recipients should receive age appropriate 'inactivated vaccine' as recommended for general population. Though trials have not been undertaken on transplant recipients, efficacy and safety of COVID-19 vaccine have been scientifically documented for few vaccines among the general population.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded403    
    Comments [Add]    
    Cited by others 1    

Recommend this journal